新冠疫情期间系统性自身免疫性炎症性风湿病发病率上升:一项地理队列研究
与大流行前平均水平相比,2020年诊断率下降(IRR 0.68,95%CI 0.64至0.72),但2021、2022和2023年保持在高于大流行前水平,2023年发病率较大流行前升高22%(IRR 1.22,95%CI 1.17至1.28,p<0.001)。
要点
- 2020年AIIRDs诊断率较大流行前下降,IRR 0.68(95%CI 0.64至0.72)。
- 2023年AIIRDs发病率较大流行前升高22%,IRR 1.22(95%CI 1.17至1.28,p<0.001)。
- 超额发病主要由原发性关节炎和系统性风湿病两类疾病诊断增加驱动。
核心结论
- 2020年AIIRDs诊断出现暂时性下降,随后2021至2023年显著增加;这一先降后升的趋势可能与COVID-19感染或预防措施(如口罩和社交距离)使用后其他感染性触发因素的减少及随后的潜在增加有关。
研究设计与样本
- 采用泊松回归分析发病率变化,计算发病率比(IRR)比较大流行期间与大流行前(2017-2019)平均发病率。
主要发现
- 7年期间共登记16254例AIIRDs诊断,大流行前AIIRDs平均发病率为4.81/万居民(95%CI 4.69至4.92)。
- 与大流行前相比,2020年诊断率下降,IRR 0.68(95%CI 0.64至0.72);2021、2022和2023年诊断率保持在高于大流行前水平。
- 2023年AIIRDs发病率较大流行前升高22%,IRR 1.22(95%CI 1.17至1.28,p<0.001)。
- 超额发病率主要由原发性关节炎和系统性风湿病两类疾病的诊断增加驱动。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The natural infection with SARS-CoV-2, or vaccination against it, has been postulated to directly contribute to an increase in the incidence of autoimmune inflammatory rheumatic diseases (AIIRDs). Conversely, preventive measures limiting access to healthcare services could have resulted in missed or delayed AIIRD diagnoses or have reduced the infection rate of any triggering infections. We aimed to define real-life trends in AIIRD diagnoses from the prepandemic period through 2023 in a large and geographically circumscribed population of 6.5 million inhabitants. METHODS: AIIRDs' annual diagnosis rates from 2017 to 2023 were derived from the registration of disease-specific exemption codes of the resident population of Lazio, a highly populated region in central Italy. Incidence rate ratios (IRRs) were calculated to compare pandemic and average prepandemic rates (2017-2019). Poisson regression was used to define statistically significant changes. RESULTS: A total of 16 254 AIIRD diagnoses were registered over the 7-year period. The average prepandemic incidence of AIIRDs was 4.81 per 10 000 inhabitants (95% CI 4.69 to 4.92). Compared with the prepandemic period, the diagnosis rate decreased in 2020 (IRR 0.68, 95% CI 0.64 to 0.72) but remained above prepandemic levels in 2021, 2022 and 2023. In 2023, there was a 22% increase in AIIRD incidence compared with prepandemic levels (IRR 1.22, 95% CI 1.17 to 1.28, p<0.001). This excess incidence was primarily driven by increases in both primary arthritides and systemic rheumatic diseases. CONCLUSIONS: We observed a temporary decline in diagnosis in 2020, followed by a substantial increase from 2021 to 2023. This trend (decline and increase) may be linked to COVID-19 infection or to the reduction and subsequently potential increase of other infectious triggers following the use of preventive measures, such as facial masks and social distancing.
引用
- De Lorenzis E, Parente P, Soldati S, et al. Rising incidence of systemic autoimmune inflammatory rheumatic diseases during the COVID-19 pandemic: a geographical cohort study. RMD Open. 2025. PMID: 40514058. doi:10.1136/rmdopen-2024-005227
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。